Evgeniy Vladimirovich Pochtar

Evgeniy Vladimirovich Pochtar

Auto-generated profile, based on publicly available information

Evgeniy Vladimirovich Pochtar

Russian Medical Academy of professional continuous education

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2021 in Russian Clinical Laboratory Diagnostics
Verified
Journal Article
Open access
EPEvgeniy Vladimirovich Pochtar
Evgeniy Vladimirovich Pochtar
SLS. A. Lugovskaya
S. A. Lugovskaya
ENE. V. Naumova
E. V. Naumova
EDE. A. Dmitrieva
E. A. Dmitrieva
AKAlexander Kostin
Alexander Kostin
VDV. V. Dolgov
V. V. Dolgov
Profound immunological dysfunction is the key factor determining the development of infectious complications in chronic lymphocytic leukemia (CLL). The aim of this work is to assess the features of the subpopulation composition of T-lymphocytes (T-helpers (Th), cytotoxic T-lymphocytes (Tcyt), T regulatory cells (Treg), T-NK cells, naive Th, Th-memory, activated T-lymphocytes, TCRγδ cells) and NK cells in peripheral blood of patients with newly diagnosed chronic lymphocytic leukemia (CLL) and receiving ibrutinib therapy. Hematological and immunophenotypic studies have been performed in 30 patients with previously untreated CLL, 122 patients on ibrutinib therapy and 20 healthy donors. The subpopulation composition of T-lymphocytes (Th, Tcyt, Treg, T-NK, naive T-helpers, memory T-helpers, TCRγδ cells, activated T-lymphocytes) and NK cells has been assessed on flow cytometer (FACSCanto II (BD)) using the following panel of monoclonal antibodies: CD45, CD19, CD3, CD4, CD5, CD8, TCRγδ, CD127, CD16, CD56, CD57 CD45RA, CD45R0, HLA-DR, CD25. Compared to controls all CLL samples were found to have higher the absolute number of T-lymphocytes, NK cells and their subpopulations, T-helpers (especially of memory T-cells), cytotoxic T-cells, regulatory T-cells, TCRγδ T-cells, activated T-lymphocytes, increased cytotoxic potential of NK cells in previously untreated CLL patients. Patients who received ibrutinib therapy have registered a positive trend towards recovery of the subpopulation composition of T-lymphocytes and NK-cells. CLL patients have been found to have quantitative and functional changes in the subpopulations of T-lymphocytes and NK cells, indicating dysregulation of the immune response, and a high risk of developing infections. Monitoring of immunological parameters for ibrutinib therapy make possible to estimate impact of ibrutinib on the adaptive anti-CLL immune response.

1 January 2024 in Immunologiya
Verified
Journal Article
Open access
EPE.V. Pochtar
E.V. Pochtar
SLS.A. Lugovskaya
S.A. Lugovskaya
ENE.V. Naumova
E.V. Naumova
MPM.E. Pochtar
M.E. Pochtar
EDE.A. Dmitrieva
E.A. Dmitrieva
AKAlexander Kostin
Alexander Kostin
Оценка субпопуляционного состава моноцитов при хроническом лимфолейкозе